{"id":"https://openalex.org/W2017009261","doi":"https://doi.org/10.1016/s1567-5688(08)70676-7","title":"DIAGNOSTIC VALUE OF HEART-TYPE FATTY ACID-BINDING PROTEIN IN COMPARISON TO TROPONIN I IN THE EARLY HOURS OF ACUTE MYOCARDIAL INFARCTION","display_name":"DIAGNOSTIC VALUE OF HEART-TYPE FATTY ACID-BINDING PROTEIN IN COMPARISON TO TROPONIN I IN THE EARLY HOURS OF ACUTE MYOCARDIAL INFARCTION","publication_year":2008,"publication_date":"2008-05-01","ids":{"openalex":"https://openalex.org/W2017009261","doi":"https://doi.org/10.1016/s1567-5688(08)70676-7","mag":"2017009261"},"language":"en","primary_location":{"id":"doi:10.1016/s1567-5688(08)70676-7","doi":"https://doi.org/10.1016/s1567-5688(08)70676-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1567-5688(08)70676-7","pdf_url":null,"source":{"id":"https://openalex.org/S120256695","display_name":"Atherosclerosis Supplements","issn_l":"1567-5688","issn":["1567-5688","1878-5050"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","ki-jl-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Atherosclerosis Supplements","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111789968","display_name":"J. Osredkar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Osredkar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053410676","display_name":"Jana Ambro\u017ei\u010d","orcid":"https://orcid.org/0000-0003-4864-7244","observed_orcids":["https://orcid.org/0000-0003-4864-7244"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Ambrozic","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5088589821","display_name":"Miran Brvar","orcid":"https://orcid.org/0000-0002-8493-3638","observed_orcids":["https://orcid.org/0000-0002-8493-3638"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Brvar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"9","issue":"1","first_page":"168","last_page":"168"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.9193999767303467,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.9193999767303467,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.04899999871850014,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/heart-type-fatty-acid-binding-protein","display_name":"heart-type fatty acid-binding protein","score":0.9850000143051147},{"id":"https://openalex.org/keywords/troponin-i","display_name":"troponin I","score":0.9909999966621399},{"id":"https://openalex.org/keywords/acute-myocardial-infarction","display_name":"acute myocardial infarction","score":0.9800000190734863},{"id":"https://openalex.org/keywords/early-diagnosis","display_name":"early diagnosis","score":0.7350000143051147},{"id":"https://openalex.org/keywords/cardiac-biomarkers","display_name":"cardiac biomarkers","score":0.7889999747276306},{"id":"https://openalex.org/keywords/chronic-heart-failure","display_name":"chronic heart failure","score":0.925000011920929},{"id":"https://openalex.org/keywords/cardiovascular-mortality","display_name":"cardiovascular mortality","score":0.6880000233650208},{"id":"https://openalex.org/keywords/hospital-readmission","display_name":"hospital readmission","score":0.7870000004768372},{"id":"https://openalex.org/keywords/brain-natriuretic-peptide","display_name":"brain natriuretic peptide","score":0.8539999723434448},{"id":"https://openalex.org/keywords/high-sensitivity-c-reactive-protein","display_name":"high-sensitivity C-reactive protein","score":0.8389999866485596},{"id":"https://openalex.org/keywords/uric-acid","display_name":"uric acid","score":0.6079999804496765},{"id":"https://openalex.org/keywords/creatinine-clearance","display_name":"creatinine clearance","score":0.8740000128746033}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8852190971374512},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.7608401775360107},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7416974306106567},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.6899700164794922},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.654634952545166},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6399863362312317},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.629855751991272},{"id":"https://openalex.org/C2779280647","wikidata":"https://www.wikidata.org/wiki/Q17927051","display_name":"Heart-type fatty acid binding protein","level":4,"score":0.6061246395111084},{"id":"https://openalex.org/C2775915353","wikidata":"https://www.wikidata.org/wiki/Q1571529","display_name":"Natriuretic peptide","level":3,"score":0.5985056161880493},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5574498176574707},{"id":"https://openalex.org/C2779881121","wikidata":"https://www.wikidata.org/wiki/Q105522","display_name":"Uric acid","level":2,"score":0.5140093564987183},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5031308531761169},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4331505000591278},{"id":"https://openalex.org/C36036425","wikidata":"https://www.wikidata.org/wiki/Q7846262","display_name":"Troponin","level":3,"score":0.41307270526885986},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.20097976922988892},{"id":"https://openalex.org/C2776834966","wikidata":"https://www.wikidata.org/wiki/Q4082494","display_name":"Fatty acid-binding protein","level":3,"score":0.16079679131507874},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.0874096155166626},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s1567-5688(08)70676-7","doi":"https://doi.org/10.1016/s1567-5688(08)70676-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1567-5688(08)70676-7","pdf_url":null,"source":{"id":"https://openalex.org/S120256695","display_name":"Atherosclerosis Supplements","issn_l":"1567-5688","issn":["1567-5688","1878-5050"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","ki-jl-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Atherosclerosis Supplements","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2161212461","https://openalex.org/W3138029590","https://openalex.org/W2039485316","https://openalex.org/W1981121371","https://openalex.org/W2104174124","https://openalex.org/W7215850334","https://openalex.org/W2085360670","https://openalex.org/W2050187676","https://openalex.org/W2035560927","https://openalex.org/W2971195270"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2016-06-24T00:00:00"}